- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Easter Bunny appears in vascular ultrasound exam
Dr. Greg Rose has uncovered radiological proof that the Easter Bunny is more than a figment of the popular imagination.
Dr. Greg Rose has uncovered radiological proof that the Easter Bunny is more than a figment of the popular imagination.
Mr. Bunny appeared while Rose, a radiologist and CEO of NightRays, was performing early morning preliminary readings via teleradiology on Feb. 21 for Clear Lake Regional Medical Center in Webster, TX. The medium of choice for the appearance was a vascular ultrasound study performed on a 36-year-old woman who had recently given birth by caesarian section. She presented to the ER with bilateral extremity swelling.
Rose could have mistaken Mr. Bunny for a patent right common femoral vein, if he had not noticed his long ears and fluffy tail and the jelly bean in his mouth.
The study was negative for deep vein thrombosis. The patient stabilized in the ER. The woman was discharged. Mr. Bunny escaped further interrogation and was last seen hoppin' down the bunny trail.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
